Species difference in the specific receptors of platelet activating factor
- 1 December 1986
- journal article
- research article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 35 (24) , 4511-4518
- https://doi.org/10.1016/0006-2952(86)90772-0
Abstract
No abstract availableThis publication has 30 references indexed in Scilit:
- INVOLVEMENT OF PLATELET ACTIVATING FACTOR IN RESPIRATORY ANAPHYLAXIS, DEMONSTRATED BY PAF-ACETHER INHIBITOR BN 52021The Lancet, 1985
- Fast atom bombardment-mass spectrometric identification of molecular species of platelet-activating factor produced by stimulated human polymorphonuclear leukocytesBiochemical and Biophysical Research Communications, 1985
- Specific binding sites for platelet activating factor in human lung tissuesBiochemical and Biophysical Research Communications, 1985
- Purification and characterization of the specific binding protein for platelet activating factor (1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine) from human platelets.The Tohoku Journal of Experimental Medicine, 1985
- Molecular heterogeneity of platelet-activating factor produced by stimulated human polymorphonuclear leukocytesBiochemical and Biophysical Research Communications, 1984
- Platelet-activating factor todayTrends in Pharmacological Sciences, 1983
- Specific receptor sites for 1-0-alkyl-2-0-acetyl-sn-glycero-3-phosphocholine (platelet activating factor) on rabbit platelet and guinea pig smooth muscle membranesBiochemistry, 1983
- CV-3988 - A specific antagonist of platelet activating factor (PAF)Life Sciences, 1983
- Estimation of hormone receptor affinity by competitive displacement of labeled ligand: Effect of concentration of receptor and of labeled ligandBiochemical and Biophysical Research Communications, 1975
- Relationship between the inhibition constant (KI) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reactionBiochemical Pharmacology, 1973